Related Experiment Video
Updated: Jul 14, 2026

Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition
Published on: June 10, 2016
Transforming growth factor-beta and fibrosis.
Franck Verrecchia1, Alain Mauviel
1INSERM U697, Hopital Saint-Louis, Pavillon Bazin, 1 avenue Claude Vellefaux, Paris 75010, France. franck.verrecchia@stlouis.inserm.fr
Transforming growth factor-beta (TGF-beta) regulates extracellular matrix (ECM) remodeling. Smad3 protein is critical in TGF-beta-induced collagen production and fibrosis development, offering potential therapeutic targets.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Transforming growth factor-beta (TGF-beta) is a key cytokine regulating extracellular matrix (ECM) assembly and remodeling.
- Dysregulated TGF-beta signaling and elevated expression are linked to abnormal connective tissue deposition in fibrotic diseases.
- Smad proteins, particularly Smad3, are crucial intracellular mediators of TGF-beta signaling.
Purpose of the Study:
- To review the mechanisms of Smad protein modulation of fibrillar collagen expression.
- To elucidate the role of Smad3 in TGF-beta-induced collagen gene regulation and fibrosis.
- To highlight the therapeutic potential of targeting Smad3 in fibrotic diseases.
Main Methods:
- Literature review focusing on molecular mechanisms of TGF-beta signaling.
- Analysis of in vitro and animal model studies investigating Smad3 function.
- Examination of Smad3's role in transcriptional regulation of type I collagen.
Main Results:
- Smad3 acts as a transcription factor regulating type I collagen gene expression.
- Targeted deletion of Smad3 in animal models demonstrates its importance in fibrosis development.
- Understanding Smad3's function provides insights into fibrotic processes.
Conclusions:
- Smad3 plays a critical role in TGF-beta-mediated collagen production and fibrotic pathogenesis.
- Targeting Smad3-dependent pathways may offer novel therapeutic strategies for fibrotic diseases.
- Further research into Smad modulation of ECM is essential for developing effective treatments.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Introduction to Fibroblasts
Regulation of Angiogenesis and Blood Supply
Cirrhosis II: Pathophysiology
Healing I: Introduction
The Tumor Microenvironment

